Correction to "A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction".
Saktimayee M RoyGeorge MinasovOttavio ArancioLaura W ChicoLinda J Van EldikWayne F AndersonJeffrey C PelletierD Martin WattersonPublished in: Journal of medicinal chemistry (2020)